MIRA INFORM REPORT
|
Report Date : |
03.06.2013 |
IDENTIFICATION DETAILS
|
Name : |
POLYPHARMA TECHNOLOGIES & SCIENCES GMBH |
|
|
|
|
Registered Office : |
Große Reichenstrasse 27, Hamburg, 20457 |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
22.02.1990 |
|
|
|
|
Com. Reg. No.: |
49821 |
|
|
|
|
Legal Form : |
Private Independent |
|
|
|
|
Line of Business : |
Subject is engaged in wholesale of industrial chemicals
(aniline, printing ink, essential oils, industrial gases, chemical glues,
colouring matter, synthetic resin, methanol, paraffin, scents and
flavourings, soda, industrial salt, acids and sulphur, starch derivatives);
wholesale of fertilisers and agro-chemical products; wholesale of plastic
materials in primary forms; and wholesale of rubber. |
|
|
|
|
No. of Employees : |
12 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY - ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world
in PPP terms and Europe's largest - is a leading exporter of machinery,
vehicles, chemicals, and household equipment and benefits from a highly skilled
labor force. Like its Western European neighbors, Germany faces significant
demographic challenges to sustained long-term growth. Low fertility rates and
declining net immigration are increasing pressure on the country's social
welfare system and necessitate structural reforms. Reforms launched by the
government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to
address chronically high unemployment and low average growth, contributed to
strong growth in 2006 and 2007 and falling unemployment. These advances, as
well as a government subsidized, reduced working hour scheme, help explain the
relatively modest increase in unemployment during the 2008-09 recession - the
deepest since World War II - and its decrease to 6.5% in 2012. GDP contracted
5.1% in 2009 but grew by 4.2% in 2010, and 3.0% in 2011, before dipping to 0.7%
in 2012 - a reflection of low investment spending due to crisis-induced
uncertainty and the decreased demand for German exports from recession-stricken
periphery countries. Stimulus and stabilization efforts initiated in 2008 and
2009 and tax cuts introduced in Chancellor Angela MERKEL's second term
increased Germany's total budget deficit - including federal, state, and
municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced
the deficit to 0.8% in 2011. In 2012 Germany reached a budget surplus of 0.1%.
A constitutional amendment approved in 2009 limits the federal government to
structural deficits of no more than 0.35% of GDP per annum as of 2016 though
the target was already reached in 2012. By 2014, the federal government wants
to balance its budget. Following the March 2011 Fukushima nuclear disaster,
Chancellor Angela Merkel announced in May 2011 that eight of the country's 17
nuclear reactors would be shut down immediately and the remaining plants would
close by 2022. Germany hopes to replace nuclear power with renewable energy.
Before the shutdown of the eight reactors, Germany relied on nuclear power for
23% of its electricity generating capacity and 46% of its base-load electricity
production.
|
Source
: CIA |
COMPANY NAME & ADDRESS
Polypharma
Technologies & Sciences GmbH
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
Business Description
Polypharma Technologies & Sciences GmbH is primarily engaged in
wholesale of industrial chemicals (aniline, printing ink, essential oils, industrial
gases, chemical glues, colouring matter, synthetic resin, methanol, paraffin,
scents and flavourings, soda, industrial salt, acids and sulphur, starch
derivatives); wholesale of fertilisers and agro-chemical products; wholesale of
plastic materials in primary forms; and wholesale of rubber.
Industry
|
Industry |
Chemical Manufacturing |
|
ANZSIC 2006: |
3323 - Industrial and Agricultural
Chemical Product Wholesaling |
|
NACE 2002: |
5155 - Wholesale of chemical products |
|
NAICS 2002: |
4246 - Chemical and Allied Products
Merchant Wholesalers |
|
UK SIC 2003: |
5155 - Wholesale of chemical products |
|
UK SIC 2007: |
4675 - Wholesale of chemical products |
|
US SIC 1987: |
5169 - Chemicals and Allied Products, Not
Elsewhere Classified |
Key Executives
Name Title
Mohamed M'Barek Managing
director
Registered No.(DEU)
49821
1 - Profit & Loss Item Exchange Rate: USD
1 = EUR 0.7191895
2 - Balance Sheet Item Exchange Rate: USD 1 =
EUR 0.770327
Polypharma Technologies & Sciences GmbH
|
|||||||||||||||||||||||||||||||||
Industry Codes
ANZSIC 2006 Codes:
3323 - Industrial
and Agricultural Chemical Product Wholesaling
3720 - Pharmaceutical
and Toiletry Goods Wholesaling
NACE 2002 Codes:
5155 - Wholesale
of chemical products
5146 - Wholesale
of pharmaceutical goods
NAICS 2002 Codes:
4246 - Chemical
and Allied Products Merchant Wholesalers
424210 - Drugs
and Druggists' Sundries Merchant Wholesalers
US SIC 1987:
5169 - Chemicals
and Allied Products, Not Elsewhere Classified
5122 - Drugs,
Drug Proprietaries, and Druggists' Sundries
UK SIC 2003:
5155 - Wholesale
of chemical products
5146 - Wholesale
of pharmaceutical goods
UK SIC 2007:
4675 - Wholesale
of chemical products
4646 - Wholesale
of pharmaceutical goods
Business Description
Polypharma Technologies & Sciences GmbH is primarily engaged in
wholesale of industrial chemicals (aniline, printing ink, essential oils, industrial
gases, chemical glues, colouring matter, synthetic resin, methanol, paraffin,
scents and flavourings, soda, industrial salt, acids and sulphur, starch
derivatives); wholesale of fertilisers and agro-chemical products; wholesale of
plastic materials in primary forms; and wholesale of rubber.
Financial Data
|
|
Key Corporate Relationships
Bank: Commerzbank
Executives Report
Executives
|
|
|
|||
|
Managing director |
Managing Director |
Annual Profit &
Loss
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate
(Period Average) |
0.71919 |
0.755078 |
0.719047 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Provisions |
0.3 |
0.4 |
0.6 |
Annual Balance Sheet
Financials in: USD (mil)
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
0.1 |
0.1 |
0.1 |
|
Profits for the year |
1.3 |
1.1 |
0.5 |
|
Total
stockholders equity |
1.5 |
1.2 |
0.6 |
|
Provisions and allowances |
0.3 |
0.4 |
0.6 |
|
Total current
liabilities |
2.4 |
2.7 |
2.4 |
|
Total
liabilities (including net worth) |
4.1 |
4.3 |
3.7 |
|
Intangibles |
0.0 |
0.0 |
0.0 |
|
Total tangible
fixed assets |
0.0 |
0.0 |
0.0 |
|
Total
non-current assets |
0.0 |
0.0 |
0.0 |
|
Net stocks and work in progress |
2.3 |
2.6 |
2.4 |
|
Total
receivables |
0.1 |
0.2 |
0.7 |
|
Cash and liquid assets |
1.6 |
1.4 |
0.6 |
|
Total current
assets |
4.0 |
4.2 |
3.7 |
|
Prepaid expenses and deferred costs |
0.0 |
0.0 |
0.0 |
|
Total assets |
4.1 |
4.3 |
3.7 |
Annual Ratios
Financials in: USD (mil)
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
16.88 |
15.76 |
15.01 |
|
Acid test ratio |
7.31 |
5.94 |
5.11 |
|
Total liabilities to net worth |
0.16% |
0.22% |
0.38% |
|
Net worth to total assets |
0.04% |
0.03% |
0.02% |
|
Current liabilities to net worth |
0.16% |
0.22% |
0.38% |
|
Current liabilities to stock |
0.10% |
0.10% |
0.10% |
|
Fixed assets to net worth |
0.00% |
0.00% |
0.00% |
|
Net worth |
1.5 |
1.2 |
0.6 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.56.50 |
|
|
1 |
Rs.86.00 |
|
Euro |
1 |
Rs.73.68 |
INFORMATION DETAILS
|
Report Prepared
by : |
SMN |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.